Guo Xiaoning
Signal active
Chief Medical Officer
Contact Information
Social
Primary Organization
Neurophth Therapeutics
Founded
2016
Employees
251-500
Industry
Biotechnology, Life Science
Bio
Guo Xiaoning joined Saisheng in 2020 and is now responsible for the company's R&D management. Before joining the company, Dr. Guo served as a senior scientist at AstraZeneca Pharmaceutical Co., Ltd. from 2007 to 2011; from 2012 to 2014 as the project leader of Johnson (Shanghai) Medical Devices Co., Ltd.; from 2014 to 2018, as Covance , Inc. senior director and head of clinical drug development; and from 2018 to 2020, he has served as deputy general manager and clinical development and regulatory affairs director of Jiaochen Biomedical Technology (Shanghai) Co., Ltd.
Location
Shanghai, Shanghai, China, Asia
Jobs history
2
Neurophth Therapeutics
Chief Medical Officer
2022 - Current
SciClone Pharmaceuticals
Vice President, Head of R&D Department and Chief Medical Officer
2020 - Invalid date
Educations
1
Nanjing University
Chemistry
Profile Resume
Guo Xiaoning is the Chief Medical Officer at Neurophth Therapeutics, based in Asia. With a background in Biotechnology, Guo Xiaoning has a rich history of leadership and innovation.Guo Xiaoning studied Bachelor's degree Chemistry at Nanjing University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.